GENE EXPRESSION OF ENDOTHELIN-1 (ET-1) AND RELEASE OF MATURE PEPTIDE BY ACTIVATED HUMAN NEUTROPHILS

This publication has 11 references indexed in Scilit:

• ACTIVATED HUMAN NEUTROPHILS EXPRESS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
  Cytokine, 1998
• Interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) enhance lipopolysaccharide binding to neutrophils via CD14
  Inflammation Research, 1998
• Molecular Pharmacology and Pathophysiological Significance of Endothelin
  The Japanese Journal of Pharmacology, 1996
• The production of cytokines by polymorphonuclear neutrophils
  Immunology Today, 1995
• The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes.
  Proceedings of the National Academy of Sciences, 1992
• Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymes
  Blood, 1991
• Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14.
  The Journal of Experimental Medicine, 1991
• Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.
  The Journal of Experimental Medicine, 1990
• Colony-stimulating factors and interferon-gamma differentially affect cell surface molecules shared by monocytes and neutrophils
  Clinical and Experimental Immunology, 1990
• The Human Preproendothelin-1 Gene
  Published by Elsevier ,1989